Design and synthesis of 1,2-annulated adamantane piperidines with anti-influenza virus activity

Bioorganic and Medicinal Chemistry

Volumn 17, Issue 4, 2009, Pages 1534-1541

  Zoidis, Grigoris ^a   Kolocouris, Nicolas ^a   Naesens, Lieve ^b   Clercq, Erik De ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

1,2 Annulated adamantane piperidines; Anti influenza A virus agent; H3N2; NMR; Rimantadine

Indexed keywords

ADAMANTANE DERIVATIVE; AMANTADINE; PIPERIDINE DERIVATIVE; RIBAVIRIN; RIMANTADINE;

ANTIVIRAL ACTIVITY; ARTICLE; DRUG DESIGN; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; INFLUENZA VIRUS A; NONHUMAN;

ADAMANTANE; ANIMALS; ANTIVIRAL AGENTS; DOGS; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; PIPERIDINES; RIMANTADINE; STRUCTURE-ACTIVITY RELATIONSHIP;

INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

EID: 60049091637     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2009.01.009     Document Type: Article

References (25)

1. Ferguson N.M., Cummings D.A.T., Cauchemez S., Fraser C., Riley S., Meeyai A., Iamsirithaworn S., and Burke D.S. Nature 437 (2005) 209
2. Ferguson N.M., Cummings D.A.T., Fraser C., Cajka J.C., Cooley P.C., and Burke D.S. Nature 442 (2006) 448
3. Kaye D., and Pringle C.R. Clin. Infect. Dis. 40 (2005) 108
4. Beigel J.H., Farrar J., Han A.M., Hayden F.G., Hyer R., De Jong M.D., Lochindarat S., Tien N.T.K., Hien N.T., Hien T.T., Nicoll A., Touch S., and Yuen K.Y. N. Engl. J. Med. 353 (2005) 1374
5. Belshe R.B. N. Engl. J. Med. 353 (2005) 2209
6. De Clercq E., and Neyts J. Trends. Pharmacol. Sci. 28 (2007) 280
7. Hay A.J., Wolstenholme A.J., Skehel J.J., and Smith M.H. EMBO J. 4 (1985) 3021
8. Hay A.J. Semin. Virol. 3 (1992) 21
9. Pinto L.H., Holsinger L.J., and Lamb R.A. Cell 69 (1992) 517
10. Samson M.S., and Kerr I.D. Protein Eng. 6 (1993) 65
11. In: Wolff M.E. (Ed). Burger's Medicinal Chemistry (1998), John Wiley & Sons, New York 590 Part II
12. Kolocouris N., Foscolos G.B., Kolocouris A., Marakos P., Pouli N., Fytas G., Ikeda S., and De Clercq E. J. Med. Chem. 37 (1994) 2896
13. Kolocouris N., Kolocouris A., Foscolos G.B., Fytas G., Neyts J., Padalko E., Balzarini J., Snoeck R., Graciela A., and De Clercq E. J. Med. Chem 39 (1996) 3307
14. Zoidis G., Kolocouris N., Foscolos G.B., Kolocouris A., Fytas G., Karayannis P., Padalko E., Neyts J., and De Clercq E. Antiviral Chem. Chemother. 14 (2003) 153
15. Zoidis G., Fytas C., Papanastasiou I., Foscolos G.B., Fytas G., Padalko E., De Clercq E., Naesens L., Neyts J., and Kolocouris N. Bioorg. Med. Chem. 14 (2006) 3341
16. Kolocouris N., Zoidis G., Foscolos G.B., Fytas G., Prathalingham R.S., Kelly J.M., Naesens L., and De Clercq E. Bioorg. Med. Chem. Lett. 17 (2007) 4358
17. Zoidis G., Tsotinis A., Kolocouris N., Kelly J.M., Prathalingham R.S., Naesens L., and De Clercq E. Org. Biomol. Chem. 6 (2008) 3177
18. De Clercq E. Nat. Rev. Drug Disc. 5 (2006) 1015
19. Kolocouris N., Zoidis G., and Fytas C. Synlett 7 (2007) 1063
20. Farcasiu D. J. Am. Chem. Soc. 98 (1976) 5301
21. Fames J., and Warren S. Tetrahedron Lett. 37 (1996) 3525
22. Anderson A., and Freenor F. J. Org. Chem. 37 (1972) 626
23. Badger G.M., Cook J.W., and Walker T. J. Chem. Soc. (1948) 2011
24. Wadsworth Jr. W.S., and Emmons W.D. Org. Synth. 45 (1965) 44
25. Stamatiou G., Foscolos G.B., Fytas G., Kolocouris A., Kolocouris N., Pannecouque C., Witvrouw M., Padalko E., Neyts J., and De Clercq E. Bioorg. Med. Chem. 11 (2003) 5485